This article originally appeared in Clinical Infectious Diseases 2010;50:S260–S266
© 2010 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2010/5010S3-0026$15.00
DOI: 10.1086/651500

Many antibiotics used today to fight and control M. tb infection target cell wall synthesis or DNA replication, and related pathogen growth mechanisms. A recent report by Zhou et al. in PNAS at the beginning of year, suggested an alternate mechanism for M. tb elimination; targeting MptpB, a mycobacterium specific protein tyrosine phosphatase.

This article originally appeared in The Guardian

The fund that fights killer diseases such as TB and Aids needs to build on its success, but it is facing a fiscal crisis

by Jeffrey Sachs